Management ChangeApr 30, 2026, 04:16 PM
DNA X CEO Liu, CCO Becher Resign; Severance Details
AI Summary
DNA X, Inc. announced the resignations of CEO Peter Liu and CCO Charles Becher, effective January 2026. Mr. Liu received a cash severance of $855,000, while Mr. Becher received $250,000, both including accelerated vesting of stock options. Mike Mulica was appointed Acting CEO in January 2026. The company also filed an amendment to its Form 10-K to include inadvertently excluded exhibits and new officer certifications, and disclosed details on director and executive compensation, and share ownership. Two instances of delinquent Section 16 reports were noted.
Key Highlights
- Former CEO Peter Liu resigned effective January 30, 2026.
- Former CCO Charles Becher resigned effective January 29, 2026.
- Peter Liu received $855,000 cash severance and accelerated stock options.
- Charles Becher received $250,000 cash severance and accelerated stock options.
- Mike Mulica was appointed Acting Chief Executive Officer in January 2026.
- George Thangadurai and DNA Holdings Venture Inc. filed late Section 16 reports.
- CFO Clay Crolius's 2025 base salary was $320,000.
- Non-employee directors receive an annual cash retainer of $35,000.